openPR Logo
Press release

mRNA Synthesis and Manufacturing Services Market Growth Driven by Increasing Demand for Infectious Disease Vaccines and Advanced Therapeutics

12-11-2025 08:36 AM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

mRNA Synthesis and Manufacturing Services Market

mRNA Synthesis and Manufacturing Services Market

InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global mRNA Synthesis and Manufacturing Services Market (by Type of Industry (Therapeutics and Vaccine Developers, CDMO Organizations, Custom Synthesis/Other Service Providers), Applications (Infectious Disease Vaccines, Other Vaccines, Therapeutics and Others), Scale of Operation (Research / Preclinical, Clinical, Commercial))- Market Outlook and Industry Analysis 2034"

Global mRNA Synthesis and Manufacturing Services Market Size is valued at USD 958.52 Mn in 2024 and is predicted to reach USD 2,294.90 Mn by the year 2034 at a 7.7% CAGR during the forecast period for 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1185

Messenger RNA (mRNA) molecules, comprising single-stranded nucleic acids transcribed from DNA, serve a critical function in gene expression by guiding the production of specific proteins within cells. Due to their inherent flexibility and adaptability, mRNA platforms have emerged as a pivotal foundation for the development of both therapeutic and prophylactic vaccines targeting a wide spectrum of infectious and chronic diseases.

Compared with traditional pharmaceutical approaches, mRNA vaccines offer enhanced immunogenicity, higher success rates, and more cost-effective manufacturing processes. The global deployment of mRNA-based COVID-19 vaccines, followed by regulatory approvals for additional viral pathogens, has markedly accelerated the demand for mRNA manufacturing capabilities.

Beyond vaccines, mRNA therapeutics exhibit significant promise for treating complex conditions, including infectious diseases, metabolic genetic disorders, oncology indications, and cardiovascular and cerebrovascular diseases. These therapies present no risk of unintended infection or insertional mutagenesis, providing a notable advantage over conventional gene therapy approaches. Additionally, mRNA enables sustained protein expression through continuous translation, yielding improved therapeutic efficacy relative to traditional protein- or peptide-based treatments.

The growth of the mRNA synthesis and manufacturing services sector is driven by the rising prevalence of rare diseases, such as propionic acidemia, methylmalonic acidemia, glycogen storage disorders, as well as metabolic and immunological disorders. Increasing incidences of chronic conditions, including cancer, cardiovascular disease, pulmonary disorders, and chronic kidney disease, are further amplifying market demand. Technological advancements in biopharmaceutical production have prompted service providers to expand manufacturing infrastructure and capacity to meet the growing requirements of this innovative therapeutic category.

Market expansion is further reinforced by the increasing number of clinical trials targeting oncology and infectious diseases. Current industry trends highlight elevated investment activity, strategic collaborations, mergers, and intensified research and development efforts. For example, in April 2021, U.S.-based mRNA company Arcturus Therapeutics entered into a joint venture with Japan's Axcelead, Inc., establishing a new entity in Chiba Prefecture and commencing construction of a manufacturing facility in Minamisoma City, Fukushima Prefecture. Such strategic initiatives are expected to significantly bolster sector growth and facilitate broader market adoption in the coming years.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

The expansion of mRNA synthesis and manufacturing services is, however, being hampered by a dearth of manufacturing procedures that are flexible, sustainable, and efficient in terms of cost. Also, the lengthy process of approvals and long-term clinical trials will hamper the market growth in the forecasting period.

The mRNA synthesis and manufacturing services market in North America will be driven by the availability of significant financing for research, the expansion of federal programmes toward RNA-based therapeutics, and the increasing number of clinical studies.

Some of the significant market players in the mRNA synthesis and manufacturing services market are eTheRNA (Etherna Immunotherapies), Eurogentec, Aldevron, biosynthesis, Biomay, Jena Biosciences, APExBIO, TriLink BioTechnologies, CELLSCRIPT, Thermo Fisher Scientific, New England Biolabs, BioNTech (Pfizer), Translate Bio, CureVac, Moderna, Ethris (AstraZeneca), Kernal Biologics, Silence Therapeutics, In-Cell-Art, Anima Biotch, H3 Biomedicine Inc., Tiba Biotechnology, Arcturus Therapeutics, Ionis Pharmaceuticals, Inc., Stemirna Therapeutics Co., Ltd., eFFECTOR Therapeutics, Inc., Ziphius Therapeutics NV, miRagen Therapeutics, Inc., RNAimmune (Sirnaomics), Skyhawk Therapeutics, Inc, Strand Therapeutics Inc., and other Prominent Players.

Key Developments in the Market :
• In Aug 2022, A novel enzymatic mRNA capping solution for the manufacture of mRNA was introduced by New England Biolabs® under the name Faustovirus Capping Enzyme. This new enzyme boosts the capping effectiveness and scalability for mRNA manufacturing workflows, including vaccine production.
• In Jan 2022, Pfizer and BioNTech signed a new global collaboration agreement to work together on developing the first mRNA-based shingles vaccine. Both Pfizer's antigen technology and BioNTech's proprietary mRNA technology will be utilised to develop potential product candidates. It is expected that clinical trials will begin in the second half of the year 2022.
• In Oct 2021, Silence Therapeutics and Hansoh Pharma announced a collaboration to develop therapeutics utilising Silence's mRNAi GOLDTM Platform. The upfront cash payment from Hansoh is expected to be sixteen million dollars, and the possible milestone payments for Silence might be as high as one billion three hundred million dollars.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1185

Market Segmentation:
Global mRNA Synthesis and Manufacturing Services Market, by Type of Industry 2022-2030 (Value US$ Mn)
• Therapeutics and Vaccine Developers
• CDMO Organizations
• Custom Synthesis/Other Service Providers
Global mRNA Synthesis and Manufacturing Services Market, by Applications, 2022-2030 (Value US$ Mn)
• Infectious Disease Vaccines
• Other Vaccines
• Therapeutics and Others
Global mRNA Synthesis and Manufacturing Services Market, by Scale of Operation, 2022-2030 (Value US$ Mn)
• Research / Preclinical
• Clinical
• Commercial
Global mRNA Synthesis and Manufacturing Services Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa mRNA Synthesis and Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global mRNA Synthesis and Manufacturing Services Market
 To receive an industry overview and future trends of the mRNA Synthesis and Manufacturing Services Market
 To analyze mRNA Synthesis and Manufacturing Services Market drivers and challenges
 To get information on the mRNA Synthesis and Manufacturing Services Market size (Value US$ Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the mRNA Synthesis and Manufacturing Services Market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-mrna-synthesis-and-manufacturing-services-market/1185

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release mRNA Synthesis and Manufacturing Services Market Growth Driven by Increasing Demand for Infectious Disease Vaccines and Advanced Therapeutics here

News-ID: 4310989 • Views:

More Releases from Insightace Analytic Pvt Ltd.

NAD-based Anti-Aging Market Forecast Highlighting Opportunities Across Oral, Topical, and Injectable Anti-Aging Interventions
NAD-based Anti-Aging Market Forecast Highlighting Opportunities Across Oral, Top …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global NAD-based Anti-Aging Market Size, Share & Trends Analysis Report By Type (Supplements (Topical NAD Supplements (Creams, Serums, Lip Creams, Eye Creams)) Therapeutic Products (NAD Nasal Spray, and NAD injections/NAD IV)), Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging, Others), Distribution Channel (Supermarkets & Hypermarkets, Specialty Stores, Convenience Stores, Pharmacies/Clinics, Online Stores) Trends, Industry Competition Analysis,
Cancer Registry Software Market Demand Boosted by Government and Private Initiatives
Cancer Registry Software Market Demand Boosted by Government and Private Initiat …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cancer Registry Software Market- (By Software Type (Standalone Software, Integrated Software), By Database (Public data, Commercial data), By Deployment Model (Cloud-based, On-premises), By Functionality (Cancer reporting to meet federal regulations, Patient care management, Product outcome evaluation, Medical research and clinical studies), By End-User (Government organisation and third-party administrator, Hospitals and medical practices, Research centres, Pharmaceutical,
Incontinence Pads Market Opportunities Rise with Eco-Friendly Product Innovations
Incontinence Pads Market Opportunities Rise with Eco-Friendly Product Innovation …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Incontinence Pads Market- (By Product Type (Reusable Pads, Disposable Pads), By Patient (Female Incontinence Pads, Male Incontinence Pads), By End-Use (Hospitals, Clinics, Long-term Care Facilities, Homecare Settings, Others), By Distribution Channel (Offline Sales, Hospital Pharmacies, Retail Pharmacies, Hypermarkets and Supermarkets, Online Sales)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." The Incontinence Pads Market Size
mHealth Solutions Market Exclusive Report on the Latest Revenue and Future Scope
mHealth Solutions Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global mHealth Solutions Market Size, Share & Trends Analysis Report By Product Type (Patient Management & Monitoring Apps, Medical Reference Apps, Women's health apps, Diabetes Management Apps, Medication management apps), Services (Remote monitoring services, Diagnosis & Consultation services, Treatment services, Healthcare system strengthening services, Fitness & wellness services, Prevention services), End-users (healthcare providers, healthcare payers, patients)-

All 5 Releases


More Releases for RNA

CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may